←LEUCentrus EnergyOur view: UnattractiveFull analysisעברית
Updated 16 Nov 2026
The company · 1 · Who is this company?

Centrus is a middleman in nuclear fuel

Enrichment

resold to utilities

TENEX, Orano

its Russian and French suppliers

An Ohio plant

planned, not yet costed

Centrus buys enrichment, the step that readies uranium for reactors, from Russia's TENEX and France's Orano, and resells it to utilities on long contracts. It now plans its own Ohio plant.

The company · 2 · What exactly does it sell?

Reselling enrichment is two thirds

Each $1 of sales, 2025
67%23%11%
Enrichment resoldGovernment engineering workUranium

The engineering work is mostly for the US government, building and running test centrifuges.

The company · 3 · How does it make money?

Buys enrichment cheaply, resells on long contracts

$5.1Bunder signed agreements
After 2027Russian supply ends by law
$2.2Bof cash

Centrus earns the gap between what it pays its suppliers and what utilities pay it.

Is it a good business? · 4 · What gives it an edge?

Only the plant would protect it

TENEX, Orano

make almost all it resells, so it has no edge there

US design

rules bar foreign designs for military uses

$900M

government award for the plant

An earlier plan at the same Ohio site failed, so the American design must still prove itself at scale.

Is it a good business? · 5 · What is the catch?

Others are building first

Urencoalready runs a large US plant
Oranoplans a Tennessee plant from 2031
General Matterbuilding in Kentucky

Listed rivals: SLX.AX · CCJ

Utilities can buy from whoever offers supply first, at any scale.

Is it a good business? · 6 · What does its record show?

Profit fell as trading costs rose

Sales, $M
298.3
293.8
320.2
442.0
448.7
454.5
Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025last 12 mo
Sales$298M → $454Msales, 2021 to the past year
Kept38% → 23%kept per $1 after buying supply
Profit23% → −1.3%operating profit per $1

The plant's costs land years before any plant revenue, so profit is near zero.

Is it a good business? · 7 · How much room is there to grow?

The prize is the Russian gap

About 3.4Munits a year of Russian supply ending
13 millionunits bought by US reactors, 2025
About $1.4Bwhat they paid that year

Filling the gap would be worth roughly $680M a year in sales, shared with whoever else builds.

Is it a good business? · 8 · Who is in charge?

A chief from a rival enricher

January 2024Amir Vexler became chief executive
2025a new finance chief and site head
Under 1%of Class A shares owned by directors

Vexler ran Orano's American arm, a rival enricher, before joining Centrus.

The story right now · 9 · Why does the Russian ban matter?

US law stops Russian enrichment after 2027

About 3.4Munits a year to replace
$3.0B → $5.4Bcontracts waiting on the plant
7 Decemberfirst investor day at the site

US reactors bought much of their enrichment from Russia. A US law ends that after 2027, so utilities need new suppliers, and Centrus loses the supply it resells.

The story right now · 10 · Why is the new plant risky?

Today's business ends before the new one starts

  1. Resells Russian supplyEnds after 2027.
  2. Plans its own plantContracts signed.
  3. Cost unknownNot disclosed.
  4. New shares to fund it$500M in September.

The price pays up front for a large plant at today's high enrichment prices, before its cost is known.

The story right now · 11 · What changed lately?

Contracts for the plant jump to $5.4B

$5.1Bunder signed agreements
26%fall in sales to $55.5M
$2.2Bof cash
$500Mof new shares and warrants sold

Mixed quarter

On the call the plant's cost and size were again put off to the 7 December investor day.

The story right now · 12 · What is everyone arguing about?

America's enrichment champion, or uncosted?

Many investors think

America's enrichment champion with contracts waiting

We think

Today's trading ends, and the plant is uncosted

The contracts are real and growing, the best evidence against us.

The price and our view · 13 · What is a share worth?

The price pays for a plant before its cost is known

$67.87what we think a share is worth
$67.87our value
Attractive
below $54.30
Neutral
Unattractive
above $81.44
$62.65gloomy: growth halves, less kept per $1
$67.87our estimate: experts' path, then slowing
$75.50sunny: growth beats the forecast by a quarter

Value per share in three futures. None is a prediction of the share price.

We estimate what a share is worth from the cash the business should earn over many years. Our rule: buy only when the price is at least a fifth below our estimate, as a cushion for being wrong.

The price and our view · 14 · What if it all works?

As a bet on the Ohio plant, it is fragile

Speculationthe kind of bet this is
2.2×if it works
50%kept if it fails

Multiples of the company's value when the bet was last struck, 16 Nov 2026.

The price already pays for the plant succeeding, and shareholders keep about a third if it fails.

The price and our view · 15 · How could we be wrong?

Russian supply could stop early

Russian supply stops earlyBiggest

Trading profit ends.

More new sharesShowing now

Sold in September.

The plant costs moreWatch

No figure yet.

The plant's sizeUnknown

Not disclosed.

An earlier plan at the same site failed, and rivals are building first.

The price and our view · 16 · How will we know?

7 December may cost the plant

Plant cost and size disclosedGood sign
Funded without many more sharesGood sign
Russia stops supply earlyBad sign
MAR 202731

Investor day, 7 December, then fourth-quarter results. Companies report every three months; each report is a test of the story.

Our view also changes on price alone: if the shares fall to within a fifth of our estimate, we move to Neutral.

The price and our view · 17 · So, what do we think?

A plant priced as if built, cost unknown

$67.87our value
Attractive
below $54.30
Neutral
Unattractive
above $81.44

UnattractiveHigh conviction

Centrus resells enrichment bought mostly from Russia and France, and that supply runs out after 2027. Its value rests on a new Ohio plant whose cost and size nobody has disclosed, at a site where an earlier plan failed.

↑ ↓ to move · C for contents